Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Global Central Nervous System Disorders Therapeutics Market Growth of 3.38% CAGR by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Vendors: Pfizer, Sanofi, Zogenix - Research and Markets

Research and Markets
Posted on: 07 Oct 16

Research and Markets has announced the addition of the "Global Central Nervous System Disorders Therapeutics Market 2016-2020" report to their offering.

The report forecasts the global central nervous system (CNS) disorders therapeutics market to grow at a CAGR of 3.38% during the period 2016-2020.

The report covers the present scenario and the growth prospects of the global central nervous system (CNS) disorders therapeutics market for 2016-2020.

To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-labeled drugs used for the treatment of various CNS disorders including bipolar disorders, depression, epilepsy, PD, AD, Huntington's disease (HD), multiple sclerosis (MS), schizophrenia, attention-deficit hyperactivity disorder (ADHD), migraine, and anxiety.

Questions Answered:

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Companies Mentioned Include:

  • GlaxoSmithKline
  • Pfizer
  • Eli Lilly
  • Abital Pharma
  • Aprecia Pharmaceuticals
  • Archer Pharmaceuticals
  • MSI Methylation Sciences
  • Mylan
  • Opexa
  • Opko Health
  • Par Pharmaceuticals
  • SAGE Therapeutics
  • Sanofi
  • US WorldMeds
  • Valeant Pharmaceuticals
  • Zinfandel Pharmaceuticals
  • Zogenix

Report Structure:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Pipeline portfolio

PART 06: Market landscape

PART 07: Market segmentation by type of disease

PART 08: Geographical segmentation

PART 09: Market drivers

PART 10: Impact of drivers

PART 11: Market challenges

PART 12: Impact of drivers and challenges

PART 13: Market trends

PART 14: Vendor landscape

PART 15: Appendix

PART 16: About the Author

For more information about this report visit

View source version on

Business Wire

Last updated on: 07/10/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.